Summary: Heparin-induced thrombocytopenia is one of the most difficult problems facing clinicians today. Despite recent understanding of the pathophysiology of this disorder, there are many unresolved issues about diagnosis, prevention, and treat-ment. In this article, difficulties physicians encounter when faced with a suspected heparin-induced thrombocytopenia pa-tient will be reviewed as well as our experience in 113 patients with heparin-induced thrombocytopenia which highlights the failure of current preventive strategies for heparin-induced thrombocytopenia. The experience of using warfarin in 51 pa-tients with heparin-induced thrombocytopenia will also be re-viewed. Key Words: Heparin-induced thrombosis—Heparin-induced thro...
PURPOSE OF REVIEW: The present contribution will illustrate some evolving concepts on the pathogenes...
Abstract. Background. The increasing trend of using low-molecular-weight-heparin (LMWH) versus unfra...
BACKGROUND: Unfractionated and low-molecular-weight heparin are commonly used in the prevention and ...
In heparin-induced thrombocytopenia (HIT) immuno-globulin G is formed against multimolecular complex...
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug effect induced by platelet-ac...
In clinical use for over 50 years, heparin is an important and widely used anticoagulant for the pro...
Heparin is widely used within the intensive care population,either as thromboprophylaxis, treatment ...
Summary Heparin-induced thrombocytopenia (HIT), typically occurring in the second week of he-parin t...
In this issue ofBlood, Krauel and colleagues identify two potential off-label treat-ments (rivaroxab...
Background: Heparin-induced thrombocytopenia (HIT) is a potentially serious adverse reaction caused ...
Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect in-duced by platelet-activat...
Hikmat Abdel-Razeq, Yousef IsmaelSection of Hematology and Medical Oncology, Department of Internal ...
International audienceBACKGROUND: Prognostic factors for unfavorable clinical outcome in patients wi...
Heparin-induced thrombocytopenia is an adverse drug reaction to heparin therapy leading to devastat...
Background: Patients receiving heparin for thromboprophylaxis or treatment may have new or recurrent...
PURPOSE OF REVIEW: The present contribution will illustrate some evolving concepts on the pathogenes...
Abstract. Background. The increasing trend of using low-molecular-weight-heparin (LMWH) versus unfra...
BACKGROUND: Unfractionated and low-molecular-weight heparin are commonly used in the prevention and ...
In heparin-induced thrombocytopenia (HIT) immuno-globulin G is formed against multimolecular complex...
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug effect induced by platelet-ac...
In clinical use for over 50 years, heparin is an important and widely used anticoagulant for the pro...
Heparin is widely used within the intensive care population,either as thromboprophylaxis, treatment ...
Summary Heparin-induced thrombocytopenia (HIT), typically occurring in the second week of he-parin t...
In this issue ofBlood, Krauel and colleagues identify two potential off-label treat-ments (rivaroxab...
Background: Heparin-induced thrombocytopenia (HIT) is a potentially serious adverse reaction caused ...
Heparin-induced thrombocytopenia is a prothrombotic adverse drug effect in-duced by platelet-activat...
Hikmat Abdel-Razeq, Yousef IsmaelSection of Hematology and Medical Oncology, Department of Internal ...
International audienceBACKGROUND: Prognostic factors for unfavorable clinical outcome in patients wi...
Heparin-induced thrombocytopenia is an adverse drug reaction to heparin therapy leading to devastat...
Background: Patients receiving heparin for thromboprophylaxis or treatment may have new or recurrent...
PURPOSE OF REVIEW: The present contribution will illustrate some evolving concepts on the pathogenes...
Abstract. Background. The increasing trend of using low-molecular-weight-heparin (LMWH) versus unfra...
BACKGROUND: Unfractionated and low-molecular-weight heparin are commonly used in the prevention and ...